HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

brunsvicamide B

isolated from Mycobacterium tuberculosis; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - brunsvicamide B: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - brunsvicamide B: 1

Experts

1.	Hart, Mark: 1 article (08/2006)
2.	Janning, Petra: 1 article (08/2006)
3.	Kehraus, Stefan: 1 article (08/2006)
4.	Krick, Anja: 1 article (08/2006)
5.	König, Gabriele M: 1 article (08/2006)
6.	Küpper, Frithjof C: 1 article (08/2006)
7.	Mehner, Christian: 1 article (08/2006)
8.	Müller, Daniela: 1 article (08/2006)
9.	Prinz, Heino: 1 article (08/2006)
10.	Saxena, Krishna: 1 article (08/2006)

Related Diseases

1.	Tuberculosis (Tuberculoses) 08/10/2006 - "Brunsvicamide B (2) and C (3) selectively inhibit the Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB), a potential drug target for tuberculosis therapy for which no inhibitors are known to date. "

Related Drugs and Biologics

1.	Protein Tyrosine Phosphatases

Related Therapies and Procedures

1.	Therapeutics